Fluorescence diagnostics of basal cell carcinomas comparing methyl-aminolaevulinate and aminolaevulinic acid and correlation with visual clinical tumour size

Acta Dermato-Venereologica

Volumn 91, Issue 4, 2011, Pages 398-403

  Sandberg, Carin ^a   Paoli, John ^a   Gillstedt, Martin ^a   Halldin, Christina B ^a   Larkö, Olle ^a   Wennberg, Ann Marie ^a   Ericson, Marica B ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Aminolaevulinic acid; Fuorescence contrast; Fuorescence diagnostics; Methyl aminolevulinate; Pdt; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; INFLAMMATION; MALE; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN PERMEABILITY; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AMINOLEVULINIC ACID; AUTOMATION, LABORATORY; CARCINOMA, BASAL CELL; FEMALE; FLUORESCENCE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS; SWEDEN; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79958794999     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1068     Document Type: Article

References (26)

1. Leiter U, Garbe C. Epidemiology of melanoma and nonme-lanoma skin cancer - the role of sunlight. Adv Exp Med Biol 2008; 624: 89-103.
2. Hoey SE, Devereux CE, Murray L, Catney D, Gavin A, kumar S, et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol 2007; 156: 1301-1307.
3. Wassberg C, Thorn M, Johansson AM, Bergström R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol 2001; 81: 268-272.
4. Katalinic A, Kunze U, Schafer T. Epidemiology of cuta neous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149: 1200-1206.
5. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 Suppl 61: 1-6.
6. Tinghög G, Carlsson P, Synnerstad I, Rosdahl I. Societal cost of skin cancer in Sweden in 2005. Acta Derm Venereol 2008; 88: 467-473.
7. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodyna-mic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-143.
8. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermato-logy Group. Br J Dermatol 2002; 146: 552-567.
9. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-292.
10. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Anders-son-Engels S, Svanberg S, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-840.
11. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fuorescence and fuence rate. Br J Dermatol 2008; 158: 727-733.
12. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photo-sensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996; 14: 289-304.
13. Stenquist B, Ericson MB, Strandeberg C, Mölne L, Rosén A, Larkö O, et al. Bispectral fuorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery. Br J Dermatol 2006; 154: 305-309.
14. Ericson MB, Sandberg C, Gudmundson F, Rosén A, Larkö O, Wennberg AM. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B 2003; 69: 121-127.
15. Andersson-Engels S, Canti G, Cubeddu R, Eker C, Afklinteberg C, Pifferi A, et al. Preliminary evaluation of two fuorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin. Lasers Surg Med 2000; 26: 76-82.
16. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 2002; 76: 329-334.
17. Fritsch C, Homey B, Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methy-lester. Photochem Photobiol 1998; 68: 218-221.
18. de Bruijn HS, Meijers C, van der Ploeg-van den Heuvel A, Sterenborg HJ, Robinson DJ. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate. J Photochem Photobiol B 2008; 92: 91-97.
19. Faurschou A, Wiegell SR, Wulf HC. Transepidermal water loss after photodynamic therapy, UVB radiation and topical corticosteroid is independent of infammation. Skin Res Technol 2007; 13: 202-206.
20. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nature reviews 2006; 6: 535-545.
21. Collaud S, Juzeniene A, Moan J, Lange N. on the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents 2004; 4: 301-316.
22. Sandberg C, Halldin CB, Ericson MB, Larkö O, Krogstad AL, Wennberg AM. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo. Br J Dermatol 2008; 159: 1170-1176.
23. Grapengiesser S, Ericson M, Gudmundsson F, Larkö O, Rosén A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
24. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, et al. Important factors for pain during photo-dynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408.
25. Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström S, et al. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control release 2005; 106: 350-360.
26. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 2003; 139: 1173-1177.